Digital Locations (DLOC) 10-Q12 Aug 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
Document And Entity Information	Jun. 30, 2014	Aug. 12, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Carbon Sciences, Inc.,	'
Entity Central Index Key	'0001407878	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	184,228,396
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

Condensed_Balance_Sheets

Condensed Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:	'	'
Cash	$215,071	$11,382
Prepaid expenses	16,320	3,758
Total current assets	231,391	15,140
PROPERTY AND EQUIPMENT, NET	668	1,182
OTHER ASSETS - Patents	1,784	1,784
Total assets	233,843	18,106
CURRENT LIABILITIES:	'	'
Accounts payable	193,812	217,418
Accrued expenses and other current liabilities	7,186	11,137
Accrued interest, notes payable	92,354	64,340
Derivative liability	1,252,357	2,811,962
Convertible notes payable, net of beneficial conversion feature of $0 and $8,849, respectively	166,500	157,651
Convertible notes payable, net of discount of $140,274 and $226,445, respectively	553,741	492,904
Total current liabilities	2,265,950	3,755,412
LONG-TERM LIABILITIES:	'	'
Convertible notes payable, net of discount of $263,255	41,745	'
Convertible note payable	25,000	25,000
Total long-term liabilities	66,745	25,000
Total liabilities	2,332,695	3,780,412
STOCKHOLDERS' DEFICIT:	'	'
Preferred stock, $0.001 par value; 20,000,000 shares authorized, no shares issued and outstanding	'	'
Common stock, $0.001 par value; 1,000,000,000 shares authorized, 150,004,469 and 72,134,930 shares issued and outstanding	150,006	72,135
Additional paid-in capital	11,013,326	10,614,891
Deficit accumulated during the development stage	-13,262,184	-14,449,332
Total stockholders' deficit	-2,098,852	-3,762,306
Total liabilities and stockholders' deficit	$233,843	$18,106

Condensed_Balance_Sheets_Paren

Condensed Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Preferred Stock, par or stated value	$0.00	$0.00
Preferred Stock, shares authorized	20,000,000	20,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par or stated value	$0.00	$0.00
Common Stock, shares authorized	1,000,000,000	1,000,000,000
Common Stock, shares issued	150,004,469	72,134,930
Common Stock, shares outstanding	150,004,469	72,134,930
Convertible promissory notes, beneficial conversion feature	$0	$8,849
Convertible Notes, Current	'	'
Convertible promissory notes discount	140,274	226,445
Convertible Notes, Non-Current	'	'
Convertible promissory notes discount	$263,255	'

Condensed_Statements_of_Operat

Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended		94 Months Ended
Condensed Statements of Operations (Unaudited) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Income Statement	'	'	'	'	'
REVENUE	'	'	'	'	'
OPERATING EXPENSES:	'	'	'	'	'
General and administrative	81,704	121,593	253,454	277,212	9,071,738
Research and development	'	-2,000	'	439	1,245,808
Depreciation and amortization	235	864	514	1,728	112,288
Total operating expenses	81,939	120,457	253,968	279,379	10,429,834
LOSS FROM OPERATIONS	-81,939	-120,457	-253,968	-279,379	-10,429,834
OTHER INCOME (EXPENSE):	'	'	'	'	'
Interest income	'	'	'	'	39,521
Rental income	4,500	4,500	10,500	6,750	24,750
Loss on sale of asset	'	'	'	'	-69,033
Loss on foreign exchange	'	'	'	'	-2,327
Impairment of intangible assets	'	'	'	'	-88,147
Gain (loss) on settlement of debt	5,396	-27,536	20,112	-27,536	-5,788
Gain on forgiveness of debt	'	20,000	'	20,000	122,000
Incentive fees	'	'	'	'	-1,079,800
Gain (loss) on change in derivative liability	495,027	-245,697	1,654,390	-237,146	-686,562
Penalties	'	'	'	'	-382
Interest expense	-108,445	-182,907	-243,886	-347,684	-1,086,582
Total other income (expense)	396,478	-431,640	1,441,116	-585,616	-2,832,350
INCOME (LOSS) BEFORE INCOME TAXES	314,539	-552,097	1,187,148	-864,995	-13,262,184
PROVISION FOR INCOME TAXES	'	'	'	'	'
NET INCOME (LOSS)	$314,539	($552,097)	$1,187,148	($864,995)	($13,262,184)
NET INCOME (LOSS) PER SHARE, BASIC AND DILUTED	$0	($0.04)	$0.01	($0.07)	'
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC AND DILUTED	130,028,041	13,269,334	112,376,592	12,427,683	'

Condensed_Statements_of_Cash_F

Condensed Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		94 Months Ended
Condensed Statements of Cash Flows (Unaudited) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'	'
Net income (loss)	$1,187,148	($864,995)	($13,262,184)
Adjustments to reconcile net income (loss) to net cash used in operating activities:	'	'	'
Depreciation and amortization	514	1,728	112,288
Stock compensation cost	18,735	81,175	2,260,065
Common stock issued for services	'	'	417,038
Common stock issued for incentive fees	'	'	1,079,800
Loss on sale of assets	'	'	69,033
Impairment of intangible assets	'	'	88,147
(Gain) loss on settlement of debt	-20,112	27,536	5,788
(Gain) loss on forgiveness of debt	'	-20,000	-122,000
Notes payable issued for services	'	66,150	66,150
Amortization of debt discount and beneficial conversion feature recorded to interest expense	204,123	311,530	943,860
(Gain) loss on change in derivative liability	-1,654,390	237,146	686,562
Changes in assets and liabilities:	'	'	'
Increase in prepaid expenses	-12,562	-354	-16,320
Increase (decrease) in Accounts payable	-23,606	34,111	400,782
Increase (decrease) in Accrued expenses and other current liabilities	80,839	24,115	425,415
NET CASH USED IN OPERATING ACTIVITIES	-219,311	-101,858	-6,845,576
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'
Patent expenditures	'	-200	-89,931
Purchase of property and equipment	'	'	-206,489
Proceeds from the sale of assets	'	'	24,500
NET CASH USED IN INVESTING ACTIVITIES	'	-200	-271,920
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'
Proceeds from notes payable	'	'	636,000
Proceeds from convertible notes payable	423,000	95,380	1,057,880
Advances from officer	'	'	113,000
Net proceeds from issuance of common stock	'	'	5,908,687
Repayment of advances and notes payable	'	'	-383,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	423,000	95,380	7,332,567
NET INCREASE (DECREASE) IN CASH	203,689	-6,678	215,071
CASH, BEGINNING OF THE PERIOD	11,382	14,257	'
CASH, END OF THE PERIOD	$215,071	$7,579	$215,071

1_Basis_of_Presentation_and_Go

1. Basis of Presentation and Going Concern	6 Months Ended
1. Basis of Presentation and Going Concern	Jun. 30, 2014
Notes	'
1. Basis of Presentation and Going Concern	'
	1. BASIS OF PRESENTATION AND GOING CONCERN

	Basis of Presentation
	The accompanying unaudited condensed financial statements of Carbon Sciences, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months and six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information refer to the financial statements and notes thereto included in the Company's Form 10-K for the year ended December 31, 2013.

	Going Concern
	The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate any revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, raising additional capital. The Company has obtained funds from its shareholders since its inception, and believes this funding will continue, and is also actively seeking new investors. Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business.

2_Summary_of_Significant_Accou

2. Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Notes	'
2. Summary of Significant Accounting Policies	'
	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

	Development Stage Activities and Operations
	The Company is in its initial stages of formation and has insignificant revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.


	Revenue Recognition
	The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has had no operating revenues and is in the development stage.


	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.


	Income (Loss) per Share Calculations
	The Company adopted the accounting pronouncement for income (loss) per share, which dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted income (loss) per share is the same as the basic income (loss) per share for the three months and six months ended June 30, 2014 and 2013.


	Stock-Based Compensation
	Share based payments applies to transactions in which an entity exchanges its equity instruments for goods or services, and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We follow a fair value approach using an option-pricing model, such as the Black Scholes option valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option.


	Fair Value of Financial Instruments
	Disclosures about fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2014 and December 31, 2013, the amounts reported for cash, accrued interest and other expenses, and notes payable approximate the fair value because of their short maturities.

	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

		·	Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

		·	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

		·	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2014 and December 31, 2013:

		Total	Level 1	Level 2	Level 3
	June 30, 2014:
	Derivative liability	$1,252,357	$-	$-	$1,252,357
	Convertible notes payable, net	553,741	-	-	553,741
	Long-term convertible notes payable, net	41,745	-	-	41,745

	Total liabilities measured at fair value	$1,847,843	$-	$-	$1,847,843

	December 31, 2013:
	Derivative liability	$2,811,962	$-	$-	$2,811,962
	Convertible notes payable, net of discount	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	$-	$-	$3,304,866



	Recently Issued Accounting Pronouncements

	Management reviewed new accounting pronouncements issued during the six months ended June 30, 2014 and through the date of filing this report, and believes no pronouncements are applicable to or would have a material impact on the financial statements of the Company.


	Reclassifications

	Certain amounts in the condensed financial statements for the three months and six months ended June 30, 2013 have been reclassified to conform to the presentation for the three months and six months ended June 30, 2014.

3_Capital_Stock

3. Capital Stock	6 Months Ended
3. Capital Stock	Jun. 30, 2014
Notes	'
3. Capital Stock	'
	3. CAPITAL STOCK

	At June 30, 2014, the Company’s authorized stock consisted of 1,000,000,000 shares of common stock, par value $0.001 per share. The Company is also authorized to issue 20,000,000 shares of preferred stock, par value $0.001 per share. The rights, preferences and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

	During the six months months ended June 30, 2014, the Company issued a total of 77,869,539 shares of common stock at fair value as follows: 71,869,539 shares in conversion of $152,823 convertible promissory notes, plus accrued interest payable of $7,153 and 6,000,000 shares in payment of accrued expenses of $49,623. In connection with the debt conversion, the Company reduced the derivative liability by $295,562 and debt discount by $27,478, and recognized a gain of $20,112 on conversion of the notes.

4_Stock_Options_Warrants_and_R

4. Stock Options, Warrants and Restricted Stock Awards	6 Months Ended
	Jun. 30, 2014
Notes	'
4. Stock Options, Warrants and Restricted Stock Awards	'
	4. STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK AWARDS

	Stock Options

	As of June 30, 2014, the Board of Directors of the Company granted non-qualified stock options exercisable for a total of 14,100,000 shares of common stock to its employees, officers and consultants. Stock-based compensation cost is measured at the grant date based on the value of the award granted using the Black-Scholes option pricing model, and recognized over the period in which the award vests, which is generally 25 months. Stock-based compensation expense included in general and administrative expense was $8,400 and $10,245 for the three months ended June 30, 2014 and 2013, respectively and $18,735 and $81,175 for the six months ended June 30, 2014 and 2013, respectively. As of June 30, 2014, unrecognized stock-based compensation expense was approximately $46,000.

	A summary of the Company’s stock option awards as of June 30, 2014, and changes during the six months then ended is as follows:

			Weighted Average	Weighted Average
			Exercise Price	Remaining
				Contract Term
				(Years)
		Shares

	Outstanding at December 31, 2013	14,100,000	$0.02
	Granted	-	$-
	Exercised	-	$-
	Forfeited or expired	-	$-

	Outstanding at June 30, 2014	14,100,000	$0.02	6.23

	Exercisable at June 30, 2014	5,139,000	$0.04	6.21

	Warrants

	As of June 30, 2014 and December 31, 2013, the Company had 460,000 common stock purchase warrants outstanding, with an exercise price of $0.50 per share and expiring on various dates in 2017 and 2018.

	Restricted Stock Awards

	On September 12, 2013 and amended on October 24, 2013, two consultants were each granted restricted stock awards for 15,000,000 shares of the Company’s common stock (the “RSAs”). The shares vest upon reaching certain defined milestones related to the Company’s development and construction of a gas-to-liquid plant.

	During the six months ended June 30, 2014, a total of 6,000,000 shares under the RSAs vested and were issued with a total compensation estimated at $49,623, calculated using the market price of the Company’s common stock on the date of vesting.

5_Convertible_Notes_Payable

5. Convertible Notes Payable	6 Months Ended
	Jun. 30, 2014
Notes	'
5. Convertible Notes Payable	'
	5. CONVERTIBLE NOTES PAYABLE

	Institutional Lender

	We entered into three securities purchase agreements with an institutional lender on July 8, 2013, September 16, 2013, and January 6, 2014 for the issuance of three 8% convertible promissory notes in the principal amounts of $42,500, $32,500 and $63,000, respectively. The notes are convertible into shares of our common stock at a price equal to a variable conversion price of 58% multiplied by a defined market price, representing a discount of 42%. The market price was defined as the average of the lowest three trading prices for our common stock during a ten trading day period ending on the latest complete trading day prior to the conversion date.

	During the six months ended June 30, 2014, the July 8, 2013 note was fully converted into shares of our common stock, extinguishing a total of $42,500 in principal and $1,700 in accrued interest. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $15,399.

	During the six months ended June 30, 2014, the September 16, 2013 note was fully converted into shares of our common stock, extinguishing a total of $32,500 in principal and $1,300 in accrued interest. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $19,973.

	The January 6, 2014 note had a principal balance of $63,000 at June 30, 2014. We recorded a debt discount of $63,000 related to the conversion feature of the January 6, 2014 note, along with a derivative liability at inception. During the six months ended June 30, 2014, amortization of the debt discount was recorded in the amount of $40,091, resulting in a remaining debt discount of $22,909 at June 30, 2014.

	Securities Purchase Agreement - $299,212

	Effective October 24, 2013, the remaining principal balance of certain convertible promissory notes totaling $291,443 and accrued interest of $7,769 were combined in a new 10% convertible promissory note, which matures on October 24, 2014 and which had an aggregate principal balance of $282,462 at December 31, 2013. The note is convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.006 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date. During the six months ended June 30, 2014, a total of $33,800 principal and $4,152 accrued interest were converted into shares of our common stock, resulting in a principal balance of $248,662 payable at June 30, 2014.

	Securities Purchase Agreements - Services of $244,452

	On December 31, 2012, we entered into convertible promissory notes with three individuals in exchange for services rendered in the aggregate amount of $244,452, including $185,852 with the Chairman of our Board of Directors and our former Chief Executive Officer. We entered into securities purchase agreements for the sale of 5% convertible promissory notes in the principal amount of $244,452, which are convertible into shares of our common stock at a conversion price equal to the lesser of $0.20 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes mature two years from their effective dates, or December 31, 2014, and totaled $244,452 at June 30, 2014. We recorded a debt discount of $237,742 related to the conversion feature of the notes, along with a derivative liability at inception. During the six months ended June 30, 2014, total amortization of debt discount was recorded in the amount of $59,008, resulting in a remaining debt discount of $61,951 at June 30, 2014.

	Securities Purchase Agreement - $100,000

	During 2013, we received total proceeds of $40,000 pursuant to a securities purchase agreement for the sale of 10% convertible promissory notes in the aggregate principal amount of $100,000. The notes are convertible into shares of our common stock at a price equal to a variable conversion price of the lesser of $0.09 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The notes were to mature one year from their effective date. We recorded a debt discount of $40,000 related to the beneficial conversion feature of the notes. The notes had an aggregate balance of $40,000 at June 30, 2014. During the six months ended June 30, 2014, the balance of the debt discount of $8,849 was amortized to interest expense. We were in default on the notes at June 30, 2014, and are in discussions with the lender to extend the maturity date of the notes.

	Securities Purchase Agreement - $335,000

	On February 27, 2013, we received proceeds of $25,000 pursuant to a securities purchase agreement for the sale of 10% convertible promissory notes in aggregate principal amount of $335,000 with a 10% Original Issue Discount (OID) of $35,000 (the “$335,000 SPA”). The note had an original issue discount of $4,313 and included a transfer of $2,137 principal and $4,957 accrued interest for total principal owed of $36,406. We recorded a debt discount of $25,403 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. The note had a balance of $25,122 at December 31, 2013. During the six months ended June 30, 2014, the note was fully converted into shares of our common stock, extinguishing a total of $25,122 in principal. During the six months ended June 30, 2014, the remaining debt discount of $2,137 was amortized to interest expense.

	On December 10, 2013, we received proceeds of $25,000 pursuant to the $335,000 SPA, with an original issue discount of $4,313 for total principal owed of $29,313. We recorded a debt discount of $29,313 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. The note had a balance of $29,313 at December 31, 2013. During the six months ended June 30, 2014, the note was partially converted into shares of our common stock, extinguishing a total of $18,900 in principal and resulting in a principal balance of $10,413 at June 30, 2014. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $23,770, resulting in a remaining discount of $3,856 at June 30, 2014.

	On February 20, 2014, we received proceeds of $30,000 pursuant to the $335,000 SPA, with an original issue discount of $5,175 for total principal owed of $35,175, which balance was payable at June 30, 2014. We recorded a debt discount of $35,175 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $12,528, resulting in a remaining discount of $22,647 at June 30, 2014.

	On June 25, 2014, we received proceeds of $25,000 pursuant to the $335,000 SPA, with an original issue discount of $4,313 for total principal owed of $29,313, which balance was payable at June 30, 2014. We recorded a debt discount of $29,313 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $402, resulting in a remaining discount of $28,911 at June 30, 2014.

	If the notes issued under the $335,000 SPA are repaid before 90 days, the interest rate will be zero percent (0%), otherwise a one-time interest rate of five percent (5%) will be applied to the principal sums outstanding. The notes are convertible into shares of our common stock at a price equal to the lesser of $0.72 or 70% of the lowest trading price in the 25 trading days prior to the conversion. The notes mature one year from the effective date of each advance.

	Securities Purchase Agreement – Accounts Payable of $29,500

	On March 14, 2013, we entered into a convertible promissory note in exchange for accounts payable in the amount of $29,500. We entered into securities purchase agreements for the sale of a 5% convertible promissory note in the principal amount of $29,500, which is convertible into shares of our common stock at a conversion price equal to the lesser of $0.15 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note matures two years from its effective date, or March 14, 2015, and had a balance payable of $29,500 at June 30, 2014.

	Securities Purchase Agreement - $97,000

	On May 29, 2013, we exchanged $97,000 in demand promissory notes for convertible promissory notes pursuant to a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $97,000. The notes are convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.028 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The note matured six months from the effective date, and had a balance payable of $97,000 at June 30, 2014. We were in default on the note at June 30, 2014, and are in discussions with the lender to extend the maturity dateof the note.

	Securities Purchase Agreement – Services of $25,000

	On June 4, 2013, we entered into a convertible promissory note with a member of our Board of Directors in exchange for services rendered in the amount of $25,000. We entered into securities purchase agreements for the sale of a 5% convertible promissory note in the principal amount of $25,000, which is convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.035 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note matures three years from its effective date, or June 4, 2016, and had a balance payable of $25,000 at June 30, 2014.

	Securities Purchase Agreement - $5,000 Exchanged Note

	On September 6, 2013, we exchanged a $5,000 promissory note for a convertible promissory note pursuant to a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $5,000. The note is convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.0042 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The note matured on June 30, 2014, is currently in default, and had a balance of $5,000 at June 30, 2014. During the six months ended June 30, 2014, the remaining debt discount of $1,459 was amortized to interest expense.

	Securities Purchase Agreement - $250,000

	On October 8, 2012, we entered into to a securities purchase agreement for the sale of 10% convertible promissory notes in aggregate principal amount of $250,000 (the $250,000 SPA”). The notes are convertible into shares of our common stock at a price equal to the lesser of $0.006 or 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion. The notes mature six months from the effective date of each advance.

	The lender previously advanced a total of $11,000 in August and September 2013 that was transferred to the $250,000 SPA. We recorded a debt discount of $11,000 along with a derivative liability upon transfer. The note had a balance of $11,000 at June 30, 2014. During the six months ended June 30, 2014, the remaining debt discount of $5,863 was amortized tointerest expense. We were in default on the note at June 30, 2014, and are in discussions with the lender to extend the maturity date of the note.

	On October 21, 2013, we received proceeds of $22,000 pursuant to the $250,000 SPA. We recorded a debt discount of $22,000 along with a derivative liability at inception. The note had a balance of $22,000 at June 30, 2014. During the six months ended June 30, 2014, the remaining debt discount of $13,418 was amortized to interest expense. We were in default on the note at June 30, 2014, and are in discussions with the lender to extend the maturity date of the note.

	On November 22, 2013, we received proceeds of $25,000 pursuant to the $250,000 SPA. We recorded a debt discount of $25,000 along with a derivative liability at inception. The note had a balance of $25,000 at June 30, 2014. During the six months ended June 30, 2013, the remaining debt discount of $19,613 was amortized to interest expense. We were in default on the note at June 30, 2014, and are in discussions with the lender to extend the maturity date of the note.

	Securities Purchase Agreement - $500,000

On April 18, 2014, we entered into to a securities purchase agreement for the sale of 10% convertible promissory notes in aggregate principal amount of $500,000 (the “$500,000 SPA”). The notes are convertible into shares of our common stock at a price per share equal to the lesser of: $0.003; 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion; or the lowest effective price per share granted to any person or entity to acquire common stock subsequent to the effective date of the note. The notes mature eighteen months from the effective date of each advance.

On April 18, 2014, we received proceeds of $60,000 pursuant to the $500,000 SPA, which balance was payable at June 30, 2014. We recorded a debt discount of $44,824 related to the conversion feature of the note, along with a derivative liability at inception. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $5,971, resulting in a remaining discount of $38,853 at June 30, 2014.

On May 20, 2014, we received proceeds of $45,000 pursuant to the $500,000 SPA, which balance was payable at June 30, 2014. We recorded a debt discount of $41,796 related to the conversion feature of the note, along with a derivative liability at inception. During the six months ended June 30, 2014, amortization of debt discount was recorded in the amount of $3,122, resulting in a remaining discount of $38,674 at June 30, 2014.

On June 30, 2014, we received proceeds of $200,000 pursuant to the $500,000 SPA, which balance was payable at June 30, 2014. We recorded a debt discount of $185,728 related to the conversion feature of the note, along with a derivative liability at inception, which balance was outstanding at June 30, 2014.

For purpose of estimating the fair market value of the derivative liability, we used the Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative liability at June 30, 2014 are as follows:


Stock price on the valuation date	$0.00
Conversion price for the debt	$0.001 - $0.0025
Dividend yield	0
Years to maturity	0.25 - 1.50
Risk free rate	0.11% - 0.04
Expected volatility	120.49% - 302.09

The value of the derivative liability balance at June 30, 2014 was $1,252,357.

The total gain on settlement of debt related to the conversion of notes payable into shares of our common stock was $5,396 and $20,112 for the three months and six months ended June 30, 2014, respectively.

6_Supplemental_Statement_of_Ca

6. Supplemental Statement of Cash Flows Information	6 Months Ended
6. Supplemental Statement of Cash Flows Information	Jun. 30, 2014
Notes	'
6. Supplemental Statement of Cash Flows Information	'
	6. SUPPLEMENTAL STATEMENT OF CASH FLOWS INFORMATION

	During the six months ended June 30, 2014 and 2013, the Company paid no amounts for income taxes.

	During the six months ended June 30, 2014 and 2013, the Company paid interest of $301 and $1,535, respectively.

	During the six months ended June 30, 2014, the Company had the following non-cash investing and financing activities:

	The Company issued a total of 71,869,539 shares of common stock in conversion of $152,823 in convertible notes payable, plus $7,153 of accrued interest payable, increasing common stock by $71,871, increasing additional paid-in capital by $336,077, decreasing debt discount by $27,478 and decreasing derivative liability by $295,562.

	The Company increased debt discount and derivative liability by $390,347 for the issuance of new convertible debt.

	The Company issued a total of 6,000,000 shares of common stock, which vested pursuant to RSAs, in payment of accrued expenses of $49,623, increasing common stock by $6,000 and additional paid-in capital of $43,623.

	During the six months ended June 30, 2013, the Company had the following non-cash investing and financing activities.

	The Company issued a total of 6,036,896 shares of common stock in conversion of $79,023 in convertible notes payable, plus $1,700 of accrued interest, increasing common stock by $6,037, increasing additional paid-in capital by $165,797, and decreasing derivative liability by $116,038.

	The Company exchanged demand notes for convertible promissory notes in the amount of $97,000.

7_Related_Party_Transactions

7. Related Party Transactions	6 Months Ended
7. Related Party Transactions	Jun. 30, 2014
Notes	'
7. Related Party Transactions	'
	7. RELATED PARTY TRANSACTIONS

	See Note 5 for discussion of convertible notes payable to related parties, including many lenders who are also shareholders of the Company.

	On December 12, 2012, we entered into a convertible note with the Chairman of our Board of Directors and our former Chief Executive Officer in exchange for services valued at $185,852. The principal balance of this related party note was $185,852 as of June 30, 2014 and December 31, 2013, with accrued interest payable of $13,901 and $9,293 as of June 30, 2014 and December 31, 2013, respectively.

	On June 4, 2013, we entered into a convertible note with a member of our Board of Directors in exchange for services valued at $25,000. As of June 30, 2014 and December 31, 2013, the principal balance of this related party note was $25,000, with accrued interest payable of $1,339 and $719 as of June 30, 2014 and December 31, 2013, respectively.

8_Research_Agreement

8. Research Agreement	6 Months Ended
8. Research Agreement	Jun. 30, 2014
Notes	'
8. Research Agreement	'
	8. RESEARCH AGREEMENT

	On June 18, 2014, the Company entered into a Sponsored Research Agreement (the “SRA”) with the University of California, Santa Barbara campus (“University”), pursuant to which the University will perform research work for the mutual benefit of the University and the Company. The purpose of the SRA includes the development of a low-cost and scalable method to produce large-area graphene for transparent electrode applications. The term of the SRA commenced on July 1, 2014 and will expire on June 30, 2015. The total cost to the Company will not exceed $387,730, as determined on a cost-reimbursement basis. Payment of the total cost is payable in installments as follows:

	$200,000 on or before July 1, 2014 (payment made in July 2014)
	$62,577 on October 1, 2014
	$62,577 On January 1, 2015
	$62,576 on April 1, 2015

9_Subsequent_Events

9. Subsequent Events	6 Months Ended
9. Subsequent Events	Jun. 30, 2014
Notes	'
9. Subsequent Events	'
	9. SUBSEQUENT EVENTS

	Management has evaluated subsequent events according to the requirements of ASC TOPIC 855, and has reported the following:

	On July 17, 2014, the Company issued 7,400,000 shares of its common stock to a lender in conversion of debt principal of $8,288 of a convertible promissory note dated December 10, 2013, pursuant to the $335,000 SPA and discussed in Note 5.

	On July 22, 2014, the Company issued 6,479,381 shares of its common stock to the institutional lender in conversion of debt principal of $6,285 of a convertible promissory note dated January 6, 2014 and discussed in Note 5.

	On July 28, 2014, the Company issued 6,483,146 shares of its common stock to the institutional lender in conversion of debt principal of $5,770 of a convertible promissory note dated January 6, 2014 and discussed in Note 5.

	On July 29, 2014, the Company issued 7,391,703 shares of its common stock to a lender in conversion of debt principal of $4,450 of a convertible promissory note dated December 12, 2012, discussed in Note 5, together with accrued interest of $724.

	On August 4, 2014, the Company issued 6,469,697 shares of its common stock to the institutional lender in conversion of debt principal of $4,270 of a convertible promissory note dated January 6, 2014 and discussed in Note 5.

2_Summary_of_Significant_Accou1

2. Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2014
Policies	'
Development Stage Activities and Operations	'
	Development Stage Activities and Operations
	The Company is in its initial stages of formation and has insignificant revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.
Revenue Recognition	'
	Revenue Recognition
	The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has had no operating revenues and is in the development stage.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Loss Per Share Calculations	'
	Income (Loss) per Share Calculations
	The Company adopted the accounting pronouncement for income (loss) per share, which dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted income (loss) per share is the same as the basic income (loss) per share for the three months and six months ended June 30, 2014 and 2013.
Stock-based Compensation	'
	Stock-Based Compensation
	Share based payments applies to transactions in which an entity exchanges its equity instruments for goods or services, and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We follow a fair value approach using an option-pricing model, such as the Black Scholes option valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Disclosures about fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2014 and December 31, 2013, the amounts reported for cash, accrued interest and other expenses, and notes payable approximate the fair value because of their short maturities.

	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

		·	Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

		·	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

		·	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2014 and December 31, 2013:

		Total	Level 1	Level 2	Level 3
	June 30, 2014:
	Derivative liability	$1,252,357	$-	$-	$1,252,357
	Convertible notes payable, net	553,741	-	-	553,741
	Long-term convertible notes payable, net	41,745	-	-	41,745

	Total liabilities measured at fair value	$1,847,843	$-	$-	$1,847,843

	December 31, 2013:
	Derivative liability	$2,811,962	$-	$-	$2,811,962
	Convertible notes payable, net of discount	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	$-	$-	$3,304,866

Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements

	Management reviewed new accounting pronouncements issued during the six months ended June 30, 2014 and through the date of filing this report, and believes no pronouncements are applicable to or would have a material impact on the financial statements of the Company.
Reclassifications	'
	Reclassifications

	Certain amounts in the condensed financial statements for the three months and six months ended June 30, 2013 have been reclassified to conform to the presentation for the three months and six months ended June 30, 2014.

2_Summary_of_Significant_Accou2

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)	6 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'

		Total	Level 1	Level 2	Level 3
	June 30, 2014:
	Derivative liability	$1,252,357	$-	$-	$1,252,357
	Convertible notes payable, net	553,741	-	-	553,741
	Long-term convertible notes payable, net	41,745	-	-	41,745

	Total liabilities measured at fair value	$1,847,843	$-	$-	$1,847,843

	December 31, 2013:
	Derivative liability	$2,811,962	$-	$-	$2,811,962
	Convertible notes payable, net of discount	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	$-	$-	$3,304,866

4_Stock_Options_Warrants_and_R1

4. Stock Options, Warrants and Restricted Stock Awards: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	6 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Share-based Compensation, Stock Options, Activity	'

			Weighted Average	Weighted Average
			Exercise Price	Remaining
				Contract Term
				(Years)
		Shares

	Outstanding at December 31, 2013	14,100,000	$0.02
	Granted	-	$-
	Exercised	-	$-
	Forfeited or expired	-	$-

	Outstanding at June 30, 2014	14,100,000	$0.02	6.23

	Exercisable at June 30, 2014	5,139,000	$0.04	6.21

5_Convertible_Notes_Payable_Fa

5. Convertible Notes Payable: Fair Value Inputs, Liabilities, Quantitative Information (Tables)	6 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Fair Value Inputs, Liabilities, Quantitative Information	'


	Stock price on the valuation date	$0.00
	Conversion price for the debt	$0.001 - $0.0025
	Dividend yield	0
	Years to maturity	0.25 - 1.50
	Risk free rate	0.11% - 0.04
	Expected volatility	120.49% - 302.09

2_Summary_of_Significant_Accou3

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Liabilities, Fair Value Disclosure, Recurring	$1,847,843	$3,304,866
Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	1,847,843	3,304,866
Derivative Financial Instruments, Liabilities	'	'
Liabilities, Fair Value Disclosure, Recurring	1,252,357	2,811,962
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	1,252,357	2,811,962
Convertible notes payable	'	'
Liabilities, Fair Value Disclosure, Recurring	553,741	492,904
Convertible notes payable \| Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Convertible notes payable \| Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	0	0
Convertible notes payable \| Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	553,741	492,904
Long-term convertible notes payable, net	'	'
Liabilities, Fair Value Disclosure, Recurring	41,745	'
Long-term convertible notes payable, net \| Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	0	'
Long-term convertible notes payable, net \| Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	0	'
Long-term convertible notes payable, net \| Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	$41,745	'

3_Capital_Stock_Details

3. Capital Stock (Details) (USD $)	3 Months Ended			6 Months Ended		94 Months Ended
3. Capital Stock (Details) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Dec. 31, 2013
Common Stock, shares authorized	1,000,000,000	'	'	1,000,000,000	'	1,000,000,000	1,000,000,000
Common Stock Par Value	$0.00	'	'	$0.00	'	$0.00	$0.00
Preferred Stock, shares authorized	20,000,000	'	'	20,000,000	'	20,000,000	20,000,000
Preferred Stock Par Value	$0.00	'	'	$0.00	'	$0.00	$0.00
Stock Issued During Period, Value, payment of accrued expenses	'	'	'	$49,623	'	'	'
Increase (Decrease) in Derivative Liabilities	'	'	'	'	-116,038	'	'
Increase Decrease in Debt Discount for the Period	'	'	'	-27,478	'	'	'
Gain (loss) on settlement of debt	5,396	5,396	-27,536	20,112	-27,536	-5,788	'
Principal	'	'	'	'	'	'	'
Debt Conversion, Original Debt, Amount	'	'	'	152,823	79,023	'	'
Increase (Decrease) in Derivative Liabilities	'	'	'	-295,562	'	'	'
Gain (loss) on settlement of debt	'	'	'	20,112	'	'	'
Accrued Interest	'	'	'	'	'	'	'
Debt Conversion, Original Debt, Amount	'	'	'	7,153	1,700	'	'
Common stock	'	'	'	'	'	'	'
Stock Issued During Period, Shares, Total	'	'	'	77,869,539	'	'	'
Debt Conversion, Converted Instrument, Shares Issued	'	'	'	71,869,539	'	'	'
Stock Issued During Period, Shares, payment of accrued expenses	'	'	'	6,000,000	'	'	'
Stock Issued During Period, Value, payment of accrued expenses	'	'	'	$6,000	'	'	'

4_Stock_Options_Warrants_and_R2

4. Stock Options, Warrants and Restricted Stock Awards (Details) (USD $)	6 Months Ended			6 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
			Employee Stock Option	Restricted Stock	Restricted Stock	General and Administrative Expense	General and Administrative Expense	General and Administrative Expense	General and Administrative Expense
					Common stock
Options, Outstanding	14,100,000	14,100,000	'	'	'	'	'	'	'
Fair Value Assumptions, Method Used	'Black-Scholes option pricing model	'	'	'	'	'	'	'	'
Award Vesting Period	'25 months	'	'	'	'	'	'	'	'
Allocated Share-based Compensation Expense	'	'	'	'	'	$8,400	$10,245	$18,735	$81,175
Stock Based Compensation Cost Not yet Recognized	'	'	46,000	'	'	'	'	'	'
Class of Warrant, Outstanding	460,000	'	'	'	'	'	'	'	'
Class of Warrant, Exercise Price	$0.50	'	'	'	'	'	'	'	'
Non-Option Equity Instruments, Granted	'	'	'	15,000,000	'	'	'	'	'
Equity Instruments Other than Options, Vested in Period	'	'	'	'	6,000,000	'	'	'	'
Equity Instruments Other than Options, Vested in Period, Fair Value	'	'	'	$49,623	'	'	'	'	'

4_Stock_Options_Warrants_and_R3

4. Stock Options, Warrants and Restricted Stock Awards: Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Details	'
Outstanding, Beginning Balance	14,100,000
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.02
Granted	0
Granted, Weighted Average Exercise Price	$0
Exercised	0
Exercised, Weighted Average Exercise Price	$0
Forfeited or expired	0
Forfeited or expired, Weighted Average Exercise Price	$0
Outstanding, Ending Balance	14,100,000
Outstanding, Weighted Average Exercise Price, Ending Balance	$0.02
Outstanding, Weighted Average Remaining Contractual Term	'6 years 2 months 23 days
Exercisable	5,139,000
Exercisable, Weighted Average Exercise Price	$0.04
Exercisable, Weighted Average Remaining Contract Term	'6 years 2 months 16 days

5_Convertible_Notes_Payable_De

5. Convertible Notes Payable (Details) (USD $)

3 Months Ended

6 Months Ended

94 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Sep. 16, 2013

Jun. 30, 2014

Jan. 06, 2014

Jun. 30, 2014

Jul. 08, 2013

Dec. 12, 2012

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Oct. 24, 2013

Jun. 30, 2014

Oct. 24, 2013

Jun. 30, 2014

Dec. 31, 2012

Jun. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2014

Dec. 31, 2012

Dec. 31, 2013

Feb. 27, 2013

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 10, 2013

Jun. 30, 2014

Mar. 31, 2014

Feb. 20, 2014

Jun. 30, 2014

Jun. 25, 2014

Mar. 31, 2014

Jun. 30, 2014

Mar. 14, 2013

Jun. 30, 2014

Mar. 31, 2014

29-May-13

Jun. 30, 2014

Jun. 04, 2013

Jun. 30, 2014

Sep. 06, 2013

Jun. 30, 2014

Oct. 08, 2013

Oct. 08, 2012

Jun. 30, 2014

Oct. 08, 2013

Jun. 30, 2014

Oct. 21, 2013

Jun. 30, 2014

Nov. 22, 2013

Jun. 30, 2014

Apr. 18, 2014

Jun. 30, 2014

20-May-14

Apr. 18, 2014

20-May-14

Jun. 30, 2014

Principal

Accrued Interest

Convertible Promissory Note 1a

Convertible Promissory Note 1b

Convertible Promissory Note 1

Convertible Promissory Note

Convertible Promissory Note 2

Convertible Promissory Note 3

Convertible Promissory Note 4

Convertible Promissory Note 5

Convertible Promissory Note 6

Convertible Promissory Note 7

Convertible Promissory Note 8

Convertible Promissory Note 9

Convertible Promissory Note 10

Convertible Promissory Note 11

Convertible Promissory Note 12

Convertible Promissory Note 13

Convertible Promissory Note 14

Principal

Accrued Interest

Board of Directors Chairman

Principal

Accrued Interest

Principal

Accrued Interest

Board of Directors Chairman

Principal

Original Issue Discount

Principal

Advance 1

Advance 2

Advance 3

Advance 1

Advance 2

Advance 3

Board of Directors Chairman

Debt Instrument, Interest Rate, Stated Percentage

8.00%

10.00%

5.00%

10.00%

5.00%

10.00%

5.00%

10.00%

Debt Instrument, Face Amount

$32,500

$63,000

$42,500

$185,852

$13,901

$9,293

$282,462

$291,443

$7,769

$244,452

$185,852

$100,000

$335,000

$29,313

$35,175

$29,313

$29,500

$97,000

$25,000

$5,000

$250,000

$11,000

$22,000

$25,000

$500,000

$60,000

$45,000

$200,000

Debt Instrument, Convertible, Terms of Conversion Feature

'The notes are convertible into shares of our common stock at a price equal to a variable conversion price of 58% multiplied by a defined market price, representing a discount of 42%. The market price was defined as the average of the lowest three trading prices for our common stock during a ten trading day period ending on the latest complete trading day prior to the conversion date

'The note is convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.006 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date.

'convertible into shares of our common stock at a conversion price equal to the lesser of $0.20 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.

'The notes are convertible into shares of our common stock at a price equal to a variable conversion price of the lesser of $0.09 per share or fifty percent (50%) of the lowest trade price recorded after the effective date

'If the notes issued under the $335,000 SPA are repaid before 90 days, the interest rate will be zero percent (0%), otherwise a one-time interest rate of five percent (5%) will be applied to the principal sums outstanding. The notes are convertible into shares of our common stock at a price equal to the lesser of $0.72 or 70% of the lowest trading price in the 25 trading days prior to the conversion

'convertible into shares of our common stock at a conversion price equal to the lesser of $0.15 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion

'The notes are convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.028 per share or fifty percent (50%) of the lowest trade price recorded after the effective date

'convertible promissory note in the principal amount of $25,000, which is convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.035 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion

'The note is convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.0042 per share or fifty percent (50%) of the lowest trade price recorded after the effective date

'The notes are convertible into shares of our common stock at a price equal to the lesser of $0.006 or 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion

'The notes are convertible into shares of our common stock at a price per share equal to the lesser of: $0.003; 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion; or the lowest effective price per share granted to any person or entity to acquire common stock subsequent to the effective date of the note

Debt Conversion, Original Debt, Amount

152,823

79,023

7,153

1,700

32,500

1,300

42,500

1,700

33,800

4,152

25,122

18,900

Amortization of debt discount and beneficial conversion feature recorded to interest expense

204,123

311,530

943,860

19,973

40,091

15,399

59,008

8,849

2,137

23,770

12,528

402

1,459

5,863

13,418

19,613

Convertible notes payable

166,500

157,651

63,000

248,662

40,000

36,406

25,122

10,413

29,313

29,500

97,000

25,000

5,000

11,000

22,000

25,000

Convertible promissory notes discount

22,909

63,000

61,951

237,742

40,000

25,403

3,856

29,313

22,647

35,175

28,911

29,313

22,000

25,000

185,728

41,796

44,824

Debt Instrument, Maturity Date

24-Oct-14

31-Dec-14

14-Mar-15

4-Jun-16

30-Jun-14

Proceeds from notes payable

636,000

40,000

25,000

30,000

25,000

Original issue discount percent

10.00%

Original issue discount

35,000

4,313

5,175

4,313

Derivative liability

1,252,357

2,811,962

Gain (loss) on settlement of debt

$5,396

($27,536)

$20,112

($27,536)

($5,788)

$20,112

5_Convertible_Notes_Payable_Fa1

5. Convertible Notes Payable: Fair Value Inputs, Liabilities, Quantitative Information (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Stock price on the valuation date	$0.00
Dividend yield	0.00%
Minimum	'
Conversion price for the debt	$0.00
Years to maturity	'3 months
Risk free rate	0.11%
Expected volatility	120.49%
Maximum	'
Conversion price for the debt	$0.00
Years to maturity	'1 year 6 months
Risk free rate	0.04%
Expected volatility	302.09%

6_Supplemental_Statement_of_Ca1

6. Supplemental Statement of Cash Flows Information (Details) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Income Taxes Paid	$0	$0
Interest Paid	301	1,535
Increase Decrease in Debt Discount for the Period	-27,478	'
Increase (Decrease) in Derivative Liabilities	'	-116,038
Stock Issued During Period, Value, payment of accrued expenses	49,623	'
Convertible Promissory Note	'	'
Debt Conversion, Converted Instrument, Amount	'	97,000
Convertible Notes, Non-Current	'	'
Increase (Decrease) in Derivative Liabilities	-390,347	'
Principal	'	'
Debt Conversion, Original Debt, Amount	152,823	79,023
Increase (Decrease) in Derivative Liabilities	-295,562	'
Accrued Interest	'	'
Debt Conversion, Original Debt, Amount	7,153	1,700
Common stock	'	'
Stock Issued During Period, Shares, Conversion of Convertible Securities	71,869,539	6,036,896
Stock Issued During Period, Value, Conversion of Convertible Securities	71,871	6,037
Stock Issued During Period, Value, payment of accrued expenses	6,000	'
Common stock \| Restricted Stock	'	'
Equity Instruments Other than Options, Vested in Period	6,000,000	'
Additional Paid-in Capital	'	'
Stock Issued During Period, Value, Conversion of Convertible Securities	336,077	165,797
Stock Issued During Period, Value, payment of accrued expenses	$43,623	'

7_Related_Party_Transactions_D

7. Related Party Transactions (Details) (USD $)

Jul. 08, 2013

Dec. 12, 2012

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Oct. 24, 2013

Jun. 04, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Convertible Promissory Note 1

Convertible Promissory Note 2

Board of Directors Chairman

Principal

Accrued Interest

Director

Principal

Accrued Interest

Principal

Accrued Interest

Debt Instrument, Face Amount

$42,500

$185,852

$13,901

$9,293

$282,462

$291,443

$7,769

$25,000

$1,339

$719

8_Research_Agreement_Details

8. Research Agreement (Details) (USD $)	6 Months Ended
8. Research Agreement (Details) (USD $)	Jun. 30, 2014
Details	'
Sponsored Research Agreement Total Cost	$387,730
Sponsored Research Agreement Payment Schedule Description	'$200,000 on or before July 1, 2014 (payment made in July 2014) $62,577 on October 1, 2014 $62,577 On January 1, 2015 $62,576 on April 1, 2015

9_Subsequent_Events_Details

9. Subsequent Events (Details) (USD $)	6 Months Ended				0 Months Ended			6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Aug. 04, 2014	Jul. 22, 2014	Jul. 17, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014
	Principal	Principal	Accrued Interest	Accrued Interest	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event
								28-Jul-14	29-Jul-14	29-Jul-14	29-Jul-14
										Principal	Accrued Interest
Debt Conversion, Converted Instrument, Shares Issued	'	'	'	'	6,469,697	6,479,381	7,400,000	6,483,146	7,391,703	'	'
Debt Conversion, Original Debt, Amount	$152,823	$79,023	$7,153	$1,700	$4,270	'	$8,288	$5,770	'	$4,450	$724
Debt Conversion, Converted Instrument, Amount	'	'	'	'	'	$6,285	'	'	'	'	'